(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 29.16% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.66%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.11%.
Glaukos's revenue in 2026 is $469,820,000.On average, 18 Wall Street analysts forecast GKOS's revenue for 2026 to be $35,870,292,520, with the lowest GKOS revenue forecast at $34,086,943,843, and the highest GKOS revenue forecast at $37,395,184,867. On average, 16 Wall Street analysts forecast GKOS's revenue for 2027 to be $45,731,263,030, with the lowest GKOS revenue forecast at $40,407,636,980, and the highest GKOS revenue forecast at $50,470,777,775.
In 2028, GKOS is forecast to generate $59,330,086,420 in revenue, with the lowest revenue forecast at $53,375,826,924 and the highest revenue forecast at $64,843,821,460.